Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 116
Filter
1.
Pharmazie ; 73(7): 393-395, 2018 07 01.
Article in English | MEDLINE | ID: mdl-30001773

ABSTRACT

Lycopene, the main fat-soluble pigment responsible for the red color of ripe tomatoes, is a symmetrical tetraterpene comprising eight isoprene units. In vitro and in vivo studies have shown that lycopene acts as a potent antioxidant; it is 100 times more effective than vitamin E and 125 times more effective than glutathione as an antioxidant. Here, we divided BALB/c male mice into three equal groups: control, Concanavalin A (Con A), and Con A and lycopene. The control group mice received only vehicle by intraperitoneal injection, the Con A group mice were given Con A, and the Con A and lycopene group mice received Con A and lycopene. The results showed that Con A administration increased histopathological damage, and the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), interleukin (IL)-6, interferon (IFN)-γ and tumor necrosis factor (TNF)-α were increased in serum samples whereas the levels of these compounds were significantly decreased in the Con A and lycopene group compared to the Con A group. Furthermore, we observed that lycopene led to an increase in cell viability and cell growth. The results of this study revealed that lycopene might be a useful hepatoprotective agent for reducing increased proinflammatory cytokine levels, and for increasing cell viability and cell growth.


Subject(s)
Antioxidants/pharmacology , Cell Survival/drug effects , Liver Diseases/prevention & control , Lycopene/pharmacology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Concanavalin A/toxicity , Disease Models, Animal , Interferon-gamma/blood , Interleukin-6/blood , Male , Mice , Mice, Inbred BALB C , Tumor Necrosis Factor-alpha/blood
2.
Pharmazie ; 73(3): 165-168, 2018 03 05.
Article in English | MEDLINE | ID: mdl-29544565

ABSTRACT

Recently, with the advancement of nanotechnology, various nanoparticles have been developed and used in fields such as electronics, cosmetics, and foods. However, the toxicity of nanoparticles has yet to be fully investigated. In particular, the interactions between nanoparticles and therapeutic drugs require further study. We previously reported that unmodified polystyrene nanoparticles with a particle size of 50 nm (NPP50) co-administered with paraquat (PQ) or cisplatin (CDDP) induce hepatic and kidney injury. Here, we determined if NPP50 modified with the amino group (NPP50-NH2), carboxyl group (NPP50-COOH), or palladium (Pd-NPP50) caused liver or kidney injury when co-administered with PQ or CDDP. The results showed that when NPP50-NH2, NPP50-COOH, or Pd-NPP50 was administered alone via the mouse tail vein, serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and blood urea nitrogen (BUN) did not increase or cause injury. When NPP50, NPP50-NH2, NPP50-COOH, or Pd-NPP50 was co-administered with PQ, serum levels of ALT and AST increased in the NPP50 group but did not increase in the NPP50-NH2, NPP50-COOH, or Pd-NPP50 groups. When NPP50-NH2, NPP50-COOH, or Pd-NPP50 was co-administered with CDDP, ALT, AST, and BUN values did not increase. These data suggest that injury due to the interaction of polystyrene nanoparticles with CDDP or PQ can be suppressed by changes in the surface charge of nanoparticles or by Pd modification.


Subject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Chemical and Drug Induced Liver Injury/pathology , Cisplatin/chemistry , Cisplatin/therapeutic use , Herbicides/chemistry , Herbicides/toxicity , Kidney Diseases/chemically induced , Nanoparticles/chemistry , Palladium/chemistry , Palladium/pharmacology , Paraquat/chemistry , Paraquat/toxicity , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Blood Urea Nitrogen , Kidney Diseases/pathology , Male , Mice , Mice, Inbred BALB C , Particle Size , Polystyrenes
3.
Pharmazie ; 72(1): 10-16, 2017 Jan 10.
Article in English | MEDLINE | ID: mdl-29441891

ABSTRACT

Nanomaterials are frequently used in microelectronics, cosmetics, and sunscreens. Platinum reagents are commonly used in disease diagnosis, cosmetics, and the food industry. Although research into the development of nanomaterialbased drug delivery systems has yielded promising results, the toxicity of these materials is not fully understood. We investigated the toxicity and drug interactions of 1- and 8-nm diameter platinum nanoparticles (nPt1 and nPt8, respectively) in mice. Acute hepato-renal toxicity of intravenously administered platinum nanoparticles was evaluated biochemically and histologically. Dose-dependent increases in serum markers of hepato-renal function (serum aminotransferases and blood urea nitrogen) were observed following administration of nPt1, whereas nPt8 had no effect, even at 20 mg/kg. Moreover, nPt1 induced interleukin (IL)-6 and IL-1ß production 3 and 6 hours after administration. The effect of nPts on drug-induced toxicity was evaluated in mice injected intraperitoneally with carbon tetrachloride or cisplatin, with or without intravenous administration of platinum nanoparticles. All treatments in the absence of nanoparticles were non-lethal and resulted in moderate toxicity. However, exacerbated toxicity was observed in mice injected with carbon tetrachloride or cisplatin together with nPt1, but not in mice co-injected with nPt8. We found that nPt1 cause hepato-renal damage, and the effect is enhanced by chemical inducers of hepatotoxicity and nephrotoxicity. This is the first report demonstrating that nPt1 not only are hepatotoxic and nephrotoxic but also exacerbate drug toxicity. These findings will be useful for future nanotechnology and nanoscience research.


Subject(s)
Chemical and Drug Induced Liver Injury/pathology , Kidney Diseases/chemically induced , Kidney Diseases/pathology , Metal Nanoparticles/toxicity , Platinum/toxicity , Alanine Transaminase/blood , Animals , Antineoplastic Agents/toxicity , Aspartate Aminotransferases/blood , Blood Urea Nitrogen , Carbon Tetrachloride/toxicity , Cisplatin/toxicity , Dose-Response Relationship, Drug , Drug Interactions , Interleukin-1beta/biosynthesis , Interleukin-1beta/genetics , Interleukin-6/biosynthesis , Interleukin-6/genetics , Male , Mice , Mice, Inbred BALB C , Particle Size
4.
Pharmazie ; 69(9): 676-9, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25272938

ABSTRACT

We investigated whether nano-sized polystyrene particles affect drug-induced toxicity. The particles, which are widely used industrially, had diameters of 50 (NPP50), 200 (NPP200) or 1000 (NPP1000) nm. The toxic chemicals tested were acetaminophen (APAP), 5-aminosalicylic acid (5-ASA), tetracycline (TC), and sodium valproate (VPA). All treatments in the absence of the nanoparticles were non-lethal and did not result in severe toxicity. However, when mice were injected with APAP, 5-ASA or TC together with polystyrene particles, synergistic, enhanced toxicity was observed in mice injected with NPP50. These synergic effects were not observed in mice co-injected with NPP200 or NPP1000. On the other hand, co-administration of VPA and NPP50, NPP200 or NPP1000 did not elevate toxicity. The results show that NPP50 differs in hepatotoxicity depending on the drug co-administered. These findings suggest that further evaluation of the interactions between polystyrene nanoparticles and drugs is a critical prerequisite to the pharmaceutical application of nanotechnology.


Subject(s)
Acetaminophen/toxicity , Analgesics, Non-Narcotic/toxicity , Anti-Bacterial Agents/toxicity , Anti-Inflammatory Agents, Non-Steroidal/toxicity , Mesalamine/toxicity , Nanoparticles/toxicity , Polystyrenes/toxicity , Tetracycline/toxicity , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Blood Urea Nitrogen , Male , Mice , Mice, Inbred BALB C , Particle Size
5.
Pharmazie ; 67(8): 712-4, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22957437

ABSTRACT

The toxicity of nanomaterials has yet to be fully investigated. In particular, the interactions between nanomaterials and therapeutic drugs require further study. We investigated whether nano-sized polystyrene particles affect drug-induced toxicity. The particles, which are widely used industrially, had diameters of 50 (NPP50), 200 (NPP200) or 1000 (NPP1000) nm. The toxic chemicals tested were carbon tetrachloride, cisplatin (a popular anti-tumor agent), and a widely used herbicide, paraquat. Mice were treated intraperitoneally with either carbon tetrachloride (0.01 ml/kg), cisplatin (100 micromol/kg) or paraquat (50 mg/kg), with or without intravenous administration of polystyrene particles. All treatments in the absence of the nanoparticles were non-lethal and did not result in severe toxicity. However, when mice were injected with paraquat or cisplatin together with polystyrene particles, synergistic, enhanced toxicity was observed in mice injected with NPP50. These synergic effects were not observed in mice co-injected with NPP200 or NPP1000. These findings suggest that further evaluation of the interactions between polystyrene nano-particles and drugs is a critical prerequisite to the pharmaceutical application of nanotechnology.


Subject(s)
Antineoplastic Agents/toxicity , Carbon Tetrachloride/toxicity , Cisplatin/toxicity , Herbicides/toxicity , Nanoparticles/toxicity , Paraquat/toxicity , Polystyrenes/toxicity , Alanine Transaminase/blood , Animals , Antineoplastic Agents/chemistry , Aspartate Aminotransferases/blood , Blood Urea Nitrogen , Carbon Tetrachloride/chemistry , Chemical and Drug Induced Liver Injury/pathology , Cisplatin/chemistry , Herbicides/chemistry , Liver/pathology , Male , Mice , Mice, Inbred BALB C , Nanoparticles/chemistry , Paraquat/chemistry , Particle Size , Pharmaceutical Vehicles , Polystyrenes/chemistry
6.
J Periodontal Res ; 46(6): 673-81, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21644999

ABSTRACT

BACKGROUND AND OBJECTIVE: The gram-negative anaerobe Porphyromonas gingivalis has been implicated as an important pathogen in the development of adult periodontitis, and its colonization of subgingival sites is critical in the pathogenic process. We previously identified a 35 kDa surface protein (hemin binding protein 35; HBP35) from P. gingivalis that exhibited coaggregation activity, while additional analysis suggested that this protein possessed an ability to bind heme molecules. For development of passive immunotherapy for periodontal diseases, human-type monoclonal antibodies have been prepared using HBP35 as an antigen in TransChromo mice. In the present study, we focused on a single antibody, TCmAb-h13, which is known to inhibit heme binding to recombinant HBP35. The aim of our investigation was to clarify the redox-related function of HBP35 and consider the benefits of human-type monoclonal antibodies. MATERIAL AND METHODS: To examine the antigen recognition capability of TCmAbs with immunoblotting and Biacore techniques, we used the native form as well as several Cys-to-Ser variants of recombinant HBP35. RESULTS: We found that the redox state of recombinant HBP35 was dependent on two Cys residues, (48) C and (51) C, in the thioredoxin active center (WCGxCx). Furthermore, TCmAb-h13 recognized the reduced forms of recombinant HBP35, indicating its inhibitory effect on P. gingivalis growth. CONCLUSION: Hemin binding protein 35 appears to be an important molecule involved in recognition of the redox state of environmental conditions. In addition, TCmAb-h13 had an inhibitory effect on heme binding to recombinant HBP35, thereby interfering with P. gingivalis growth.


Subject(s)
Antibodies, Monoclonal, Humanized/immunology , Bacterial Proteins/immunology , Carrier Proteins/immunology , Hemeproteins/immunology , Immunization, Passive/methods , Porphyromonas gingivalis/growth & development , Amino Acid Substitution , Animals , Antibodies, Monoclonal, Humanized/chemistry , Carrier Proteins/chemistry , Cysteine , Heme-Binding Proteins , Hemeproteins/chemistry , Hemin/metabolism , Humans , Mice , Mice, Transgenic , Porphyromonas gingivalis/chemistry , Porphyromonas gingivalis/immunology , Protein Binding/immunology , Protein Structure, Tertiary , Serine , Thioredoxins/chemistry , Virulence Factors/immunology
7.
J Nutr Health Aging ; 15(4): 282-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21437560

ABSTRACT

OBJECTIVES: To determine the presence or extent of arginine deficiency in pressure ulcer (PU) patients on percutaneous endoscopic gastrostomy (PEG) feeding and to examine the effects of arginine supplementation on PU healing. DESIGN: All eligible PEG patients, with and without PU, were cross-sectionally assessed for plasma arginine. Three-month supplementation with arginine-enriched water (Arginaid Water) was performed on a subset of patients with PU. This intervention study was a prospective, non-controlled trial with 5 PU patients. SETTING: Geriatric ward of a rural clinical hospital in Japan. PARTICIPANTS: Thirty-nine inpatients with PEG feeding were assessed for plasma arginine. Five of the 13 patients with PU and five of 26 patients without PU underwent amino acid profiling. INTERVENTION: Five of the patients with PU received Arginaid Water supplementation. MEASUREMENTS: Plasma amino acid measurements and biochemical analyses were performed. For those with PU on Arginaid Water supplementation, plasma arginine concentration and PU status were monitored every month. RESULTS: Patients with PU showed significantly lower plasma arginine concentration compared to those without PU (control vs. PU; 80.2±21.3 vs 62.8±14.7 nmol/ml, p<0.01). After the addition of Arginaid Water, plasma arginine concentration increased (before vs 3 months later; 57.9±1.8 vs 83.1±8.5, p<0.01), and PU area, perimeter, DESIGN-R and PUSH scores significantly improved. CONCLUSION: Plasma arginine was lower in PEG patients with PU. The healing rate of PU is improved with Arginaid Water supplementation. The findings from this study support the use of arginine supplementation in PEG patients with PU.


Subject(s)
Arginine/blood , Arginine/therapeutic use , Enteral Nutrition , Pressure Ulcer/blood , Pressure Ulcer/drug therapy , Wound Healing/drug effects , Aged, 80 and over , Analysis of Variance , Arginine/deficiency , Cross-Sectional Studies , Dietary Supplements , Enteral Nutrition/adverse effects , Female , Humans , Male , Pressure Ulcer/pathology , Prospective Studies , Treatment Outcome , Wound Healing/physiology
8.
Kyobu Geka ; 63(1): 41-5, 2010 Jan.
Article in Japanese | MEDLINE | ID: mdl-20077831

ABSTRACT

The approach that should be used for an anterior apical tumor still remains controversial. Since a modified open door method was very useful for the widening of the surgical field in a recent patient with an anterior apical tumor, an outline of this case is reported. The patient was a 66-year-old male with squamous cell carcinoma of the anterior apical region of the right lung (suspected to be invading the thoracic wall, cT3N1M0). After a midline sternal incision with a right unilateral collar incision, the medial half of the right clavicle and a few cm of the right 1st rib on the sternal side were resected to sufficiently expose the area from the right brachiocephalic trunk to around the subclavicular artery and vein, where invasion was suspected. This treatment facilitated widening of the visual field around the site of tumor invasion and made safe right upper lobectomy + combined thoracic wall resection + ND2a possible. In this patient, anterolateral incision at the 4th intercostal level, which is made using the original open door method, could be avoided, probably minimizing surgical invasion.


Subject(s)
Carcinoma, Squamous Cell/surgery , Lung Neoplasms/surgery , Pancoast Syndrome/surgery , Aged , Humans , Male , Thoracic Surgical Procedures/methods
10.
Kyobu Geka ; 61(10): 836-40, 2008 Sep.
Article in Japanese | MEDLINE | ID: mdl-18788370

ABSTRACT

Primitive neuroectodermal tumor of the sternum is rare. A 59-year-old woman referred to our department with anterior chest pain and a tumor in the sternum. The patient was diagnosed as primitive neuroectodermal tumor of the sternum by core biopsy of the lesion. She received 2 cycles of preoperative chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, etoposide. She underwent a total sternectomy with resection of adjacent bilateral costal cartilages and sternal ends of the clavicles. The skeletal defect of chest wall was reconstructed by polypropylene mesh-resin sandwich. The myocutaneus defect was reconstructed by the pedicled latissimus dorsi myocutaneus flap and the bilateral breast flaps. The postoperative course was uneventful and adjuvant radiotherapy was started 6 weeks after the operation. She died of distant metastases 3 months after the operation, although this patient was free from local recurrence.


Subject(s)
Neuroectodermal Tumors, Primitive/surgery , Sternum/surgery , Thoracic Neoplasms/surgery , Thoracic Wall/surgery , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bacterial Proteins , Chemotherapy, Adjuvant , Combined Modality Therapy , Female , Humans , Membrane Transport Proteins , Middle Aged , Radiotherapy, Adjuvant , Plastic Surgery Procedures , Thoracic Surgical Procedures
11.
Int J Gynecol Cancer ; 18(5): 996-1006, 2008.
Article in English | MEDLINE | ID: mdl-18028379

ABSTRACT

In recent years, antibody therapy employing monoclonal antibodies has become a new approach for treating cancer. This study was performed to establish a human monoclonal antibody recognizing an epitope related to CA125 using KM mice and to assess its reactivity with ovarian cancer cells. A human ovarian clear cell adenocarcinoma cell line (RMG-I) was used to immunize KM mice, and hybridoma supernatant was obtained by a standard method employing enzyme-linked immunosorbent assay screening. Next, selection of hybridomas was performed with two antibodies (MA602-1 and MA602-6) and a sandwich immunoassay for CA125-like antigen, and then the limiting dilution was used to obtain a human monoclonal antibody. Immunohistochemical reactivity of this antibody (human monoclonal antibody for ovarian clear cell carcinoma-2 [HMOCC-2]) with ovarian cancer was assessed, while its specificity was analyzed by Western blotting. Various antibodies were used to identify the epitope targeted by HMOCC-2. Finally, the antitumor effect of HMOCC-2 was assessed by intraperitoneal administration to SCID (severe combined immunodeficiency) mice with heterografts of RMG-I tumors. HMOCC-2 showed a positive reaction with 60% (63/105) of ovarian cancer specimens. Western blotting of the membrane fraction of RMG-I revealed several bands at 120-250 kd. HMOCC-2 recognized the CA125-like antigens identified by several antibodies. HMOCC-2 also exhibited significant antitumor activity (P < 0.01) against ovarian cancer heterografts. HMOCC-2 reacts specifically with ovarian cancer cells via a target epitope analogous to that of CA125 and also exhibits activity against ovarian tumors. These findings suggest that it may have the potential to be employed clinically for molecular-targeting therapy.


Subject(s)
Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/therapeutic use , CA-125 Antigen/immunology , Immunotherapy , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/immunology , Animals , Cell Line, Tumor , Female , Humans , Immunohistochemistry , Mice , Xenograft Model Antitumor Assays
12.
J Laryngol Otol ; 122(9): 887-92, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18036279

ABSTRACT

OBJECTIVE: To evaluate the vestibular aqueduct in patients with sudden sensorineural hearing loss. METHODS: We evaluated 19 patients (12 men and seven women; age range, 22-79 years) with unilateral sudden sensorineural hearing loss, using computed tomography and magnetic resonance imaging. All these patients had unilateral sudden sensorineural hearing loss. We also evaluated 47 control subjects (22 men and 25 women; age range, 22-79 years). RESULTS: In sensorineural hearing loss affected ears, the width of the vestibular aqueduct at the midpoint and at the operculum was significantly greater than that in contralateral ears or in control ears. The width of the vestibular aqueduct at the midpoint and the operculum did not correlate with the audiometric threshold or the audiogram configuration. Contrast enhancement of the ipsilateral endolymphatic sac was observed in 17 of 19 patients with sudden sensorineural hearing loss (89 per cent). Eleven of these 17 patients also showed enhancement on the contralateral side, but no patient showed enhancement only on the contralateral side. In sensorineural hearing loss affected ears, the width of the vestibular aqueduct did not differ significantly between those patients with and without enhancement. CONCLUSIONS: The vestibular aqueducts of sudden sensorineural hearing loss affected ears are wider than those of controls. Precise imaging and evaluation of the inner ear is essential when investigating the pathological conditions responsible for sudden sensorineural hearing loss.


Subject(s)
Endolymphatic Sac/pathology , Hearing Loss, Sensorineural/pathology , Vestibular Aqueduct/pathology , Adult , Aged , Case-Control Studies , Female , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sensorineural/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Tomography, X-Ray Computed , Vestibular Aqueduct/diagnostic imaging
13.
Kyobu Geka ; 59(11): 990-5, 2006 Oct.
Article in Japanese | MEDLINE | ID: mdl-17058660

ABSTRACT

Blunt bronchial injury is rare but crucial injury. A 17-year-old female was admitted due to traumatic injury. She was diagnosed with bilateral lung contusion, multiple rib fractures, spleen damage and the suspicion about the complete transection of the left main bronchus on X-ray and computed tomography (CT). She was brought to our hospital at 30 hours later from injury. Bronchoscopy revealed the complete transection and the edema of the left main bronchus. She underwent a resection of the disrupted portion and end-to-end anastomosis of left main bronchus without lung resection. We should be an immediate and accurate diagnosis of tracheobronchial disruption by X-ray, CT and bronchoscopy whenever we evaluate patients with blunt chest trauma.


Subject(s)
Bronchi/injuries , Bronchi/surgery , Wounds, Nonpenetrating/surgery , Adolescent , Adult , Aged , Anastomosis, Surgical , Female , Humans , Male , Middle Aged
14.
Placenta ; 27(2-3): 333-9, 2006.
Article in English | MEDLINE | ID: mdl-16338478

ABSTRACT

The incidence of choriocarcinoma has decreased over time and therapeutic results have improved about 90% complete remission in patients without extensive metastasis. However, some choriocarcinomas metastasize to other organs and show resistance to chemotherapy, having a poor prognosis despite multidisciplinary treatment. Better methods of early diagnosis for recurrence or micrometastasis, and treatment against cases with intractable gestational trophoblastic neoplasia (GTN) are needed to improve the prognosis. Human chorionic gonadotropin (hCG) is a glycoprotein hormone composed of two dissimilar subunits and a tumor marker to make a diagnosis and monitor therapeutic effect in GTN. Even when hCG levels in the serum become too low to measure with the hCG beta-CTP system which is the most sensitive assay, there are estimated to be approximately 10,000 trophoblastic cells in the body. Residual trophoblast cells may cause symptoms such as bleeding or undergo malignant transformation to choriocarcinoma. Since most monoclonal antibodies developed so far are murine, administration creates human anti-mouse antibodies, resulting in clinical failure. More recent mouse/human chimeric antibodies or humanized antibodies still possess substantial immunogenicity that makes repeated administration difficult. In the present study, KM mice that can produce completely human monoclonal antibodies were used to prepare hCG-specific human monoclonal antibody. This yielded 8-1A, a human monoclonal antibody capable of reacting with intact hCG. In the future, new diagnostic techniques and treatments for chorionic diseases may be developed using this kind of human monoclonal antibody.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/immunology , Chorionic Gonadotropin/immunology , Animals , Antibodies, Monoclonal, Humanized , Blotting, Western , Humans , Immunochemistry , Immunoprecipitation , Mice , Mice, Transgenic
15.
Kyobu Geka ; 58(9): 813-7, 2005 Aug.
Article in Japanese | MEDLINE | ID: mdl-16104568

ABSTRACT

UNLABELLED: We here presented 2 cases of interstitial pneumonia with lung adenocarcinoma incidentally diagnosed by partially resected lung for diffuse pulmonary disease. CASE 1: A 78-year-old female was admitted to the hospital complaining of productive cough and general fatigue. The chest computed tomography (CT) revealed diffuse honey comb pattern in bilateral lung field especially in the right lower lung. Video-assisted thoracoscopic lung biopsy was performed and was diagnosed as diffuse spreading well differentiated adenocarcinoma. CASE 2: A 59-year-old male was admitted to the hospital complaining of dyspnea and general fatigue. The chest X-ray revealed right pneumothorax and chest CT revealed diffuse honey comb pattern and bullae in bilateral lung field and fibrous tumor-like lesion in the right middle lung. Video-assisted thoracoscopic lung biopsy was performed and was diagnosed as pulmonary fibrosis with papillary adenocarcinoma. CONCLUSION: It is important to examine carefully the specimen obtained from thoracoscopic lung biopsy even if interstitial pneumonia is strongly suspected.


Subject(s)
Adenocarcinoma/diagnosis , Lung Diseases, Interstitial/pathology , Lung Neoplasms/diagnosis , Lung/pathology , Thoracic Surgery, Video-Assisted , Aged , Biopsy/methods , Female , Humans , Lung Diseases, Interstitial/diagnostic imaging , Middle Aged , Radiography, Thoracic , Tomography, X-Ray Computed
16.
Kyobu Geka ; 57(1): 61-6, 2004 Jan.
Article in Japanese | MEDLINE | ID: mdl-14733101

ABSTRACT

UNLABELLED: We analyzed 723 cases of non small cell lung cancer (459 adenocarcinomas and 264 squamous cell carcinomas) from the view point of lymph nodes metastases, according to histological type, location of cancer and tumor size. METHOD: Histological type was adenocarcinoma or squamous cell carcinoma. Location was divided into 8 areas [right side; 4 areas, upper lobe (RUL)/middle lobe (RML)/S6 (RS6)/basal segment of lower lobe (RBS): left side; 4 areas, upper division of upper lobe (LUD)/lingula (LLS)/S6 (LS6)/Basal segment of lower lobe (LBS)]. Tumor size was divided by centimeters, namely 0.0-1.0 cm, 1.1-2.0 cm, 2.1-3.0 cm, etc.. RESULTS: Safety size of lung cancer in which we can abbreviate mediastinal lymph nodes dissection was as follows. In adenocarcinoma, in RUL/RML/RBS 1.0 cm, in RS6 2.0 cm, in LUD 1.0 cm, in LLS/LS6/LBS 2.0 cm. In squamous cell carcinoma, in RUL 1.0 cm, in RML/RS6/RBS 2.0 cm, in LUD 1.0 cm, in LLS/LS6/LBS 2.0 cm. CONCLUSION: In 1.0 cm or smaller non small cell lung cancer we might abbreviate mediastinal lymph nodes dissection. Moreover, in squamous cell carcinoma of (RML, LLS, right or left lower lobe) of 2.0 cm or smaller size, we might abbreviate mediastinal lymph nodes dissection.


Subject(s)
Adenocarcinoma/surgery , Carcinoma, Squamous Cell/surgery , Lung Neoplasms/surgery , Lymph Node Excision , Lymph Nodes/pathology , Pneumonectomy , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Adenocarcinoma/secondary , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/secondary , Humans , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Lymphatic Metastasis , Survival Rate
17.
Cell Death Differ ; 11(2): 203-7, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14576771

ABSTRACT

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in tumor cells without toxicity to normal cells, but some recombinant versions of TRAIL caused hepatocyte death. We generated fully human monoclonal antibodies (mAbs) that bind specifically to TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2), which mediate apoptosis signal when they ligate with TRAIL, to investigate the contribution of each receptor to induce tumor cell apoptosis and hepatocyte toxicity. All of mAbs to TRAIL-R1 and TRAIL-R2 induced cell death in several cancer cell lines susceptible to TRAIL but not in human umbilical vein endothelial cells in vitro. Both anti-TRAIL-R1 mAbs and anti-TRAIL-R2mAbs also caused cell death in hepatocytes. However, a subset of mAbs to TRAIL-R2, which was characterized by the TRAIL blocking activity, did not show strong hepatocyte toxicity. These results indicate that human normal hepatocytes are susceptible to both TRAIL-R1- and TRAIL-R2-mediated apoptosis signal. Cell Death and Differentiation (2004) 11, 203-207. doi:10.1038/sj.cdd.4401331 Published online 24 October 2003


Subject(s)
Apoptosis , Hepatocytes/cytology , Hepatocytes/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Signal Transduction , Animals , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/toxicity , Caspases/metabolism , Cell Line, Tumor , Flow Cytometry , Humans , Mice , Mice, Transgenic , Receptors, TNF-Related Apoptosis-Inducing Ligand , Receptors, Tumor Necrosis Factor/antagonists & inhibitors , Receptors, Tumor Necrosis Factor/immunology
18.
Theriogenology ; 59(1): 107-13, 2003 Jan 01.
Article in English | MEDLINE | ID: mdl-12499022

ABSTRACT

Artificial chromosome vectors are autonomous, replicating DNA sequences containing a centromere, two telomeres and origins of replication. Artificial chromosomes have been proposed as possible vectors for transferring very large sequences of DNA into animals. Our goal has been to insert the entire human heavy- and light-chain immunoglobulin loci into cattle as a step in developing a production system for large quantities of human therapeutic polyclonal antibodies. A mitotically stable fragment of chromosome 14, containing the human heavy-chain locus, was identified. A chromosome cloning system was used to transfer the human lambda locus from an unstable chromosome 22 fragment to the chromosome 14 fragment to create a human artificial chromosome (HAC) carrying both immunoglobulin loci. The HAC vector was introduced into bovine primary fibroblasts. Selected fibroblast clones were rejuvenated and expanded by producing cloned fetuses. Cloned fetal cells were selected and recloned to produce 21 healthy, transchromosomic (Tc) calves. Four were analyzed and shown to functionally rearrange both heavy- and light-chain human immunoglobulin loci and produce human polyclonal antibodies. These results demonstrate the feasibility of using HAC vectors for production of transgenic livestock. More importantly, Tc cattle containing human immunoglobulin genes may be used to produce novel human polyclonal therapeutics.


Subject(s)
Animals, Genetically Modified , Chromosomes, Artificial/genetics , Gene Expression , Genetic Vectors , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Light Chains/genetics , Animals , Cattle/genetics , Chromosomes, Human, Pair 14 , Chromosomes, Human, Pair 22 , Cloning, Molecular , Fibroblasts/metabolism , Humans , Transfection
19.
Br J Ophthalmol ; 86(12): 1428-33, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12446380

ABSTRACT

AIMS: To localise Smads3/4 proteins in lens epithelial cells (LECs) of fresh and postoperative human specimens. Smads3/4 are involved in signal transduction between transforming growth factor beta (TGFbeta) cell surface receptors and gene promoters. Nuclear localisation of Smads indicates achievement of endogenous TGFbeta signalling in cells. METHODS: Three circular sections of the anterior capsule, one lens, and 17 capsules undergoing postoperative healing were studied. Immunohistochemistry was performed for Smads3/4 in paraffin sections of the specimens. The effect of exogenous TGFbeta2 on Smad3 subcellular localisation was examined in explant cultures of extracted human anterior lens epithelium. RESULTS: The cytoplasm, but not the nuclei, of LECs of uninjured lenses was immunoreactive for Smads3/4. In contrast, nuclear immunoreactivity for Smads3/4 was detected in LECs during capsular healing. Nuclei positive for Smads3/4 were observed in monolayered LECs adjacent to the regenerated lens fibres of Sommerring's ring. Interestingly, the nuclei of LECs that were somewhat elongated, and appeared to be differentiating into fibre-like cells, were negative for Smads3/4. Fibroblast-like, spindle-shaped lens cells with nuclear immunoreactivity for nuclear Smads3/4 were occasionally observed in the extracellular matrix accumulated in capsular opacification. Exogenous TGFbeta induced nuclear translocation of Smad3 in LECs of anterior capsule specimens in explant culture. CONCLUSIONS: This is consistent with TGFbeta induced Smad signalling being involved in regulating the behaviour of LECs during wound healing after cataract surgery.


Subject(s)
Cataract Extraction , DNA-Binding Proteins/analysis , Lens, Crystalline/chemistry , Trans-Activators/analysis , Adult , Aged , Aged, 80 and over , Cells, Cultured , Epithelial Cells/chemistry , Female , Humans , Lens, Crystalline/cytology , Male , Middle Aged , Signal Transduction , Smad3 Protein , Smad4 Protein , Wound Healing , beta-Crystallins/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...